Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004418 · ClinicalTrials.gov registry record · Phase 2
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
A Phase 2 study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Terminated
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
NCT00004418 is a Phase 2 study that was terminated before completion, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 126 participants.
The verdict
NCT00004418, a Phase 2 study, was terminated before completion, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Evaluate the clinical efficacy of combination glyceryl trierucate and glyceryl trioleate (Lorenzo's Oil) therapy in boys with X-linked adrenoleukodystrophy. II. Compare the frequency and severity of neurological disability of study patients with untreated historical controls.
Interventions
- DRUG glyceryl trierucate/glyceryl trioleate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 1998-04 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004418
The ClinicalTrials.gov registry entry for NCT00004418 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which glyceryl trierucate/glyceryl trioleate is the first listed.
NCT00004418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004418 about?
NCT00004418 is a clinical study titled "Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy". OBJECTIVES: I. Evaluate the clinical efficacy of combination glyceryl trierucate and glyceryl trioleate (Lorenzo's Oil) therapy in boys with X-linked adrenoleukodystrophy. II. Compare the frequency and severity of neurological disability of study patients with untreated historical controls.
What is the current status of trial NCT00004418?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 1998-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00004418?
The interventions under investigation include: glyceryl trierucate/glyceryl trioleate (DRUG).
Who is sponsoring clinical trial NCT00004418?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.